I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| macrophage | 17 studies | 41% ± 24% | |
| microglial cell | 12 studies | 62% ± 20% | |
| mast cell | 11 studies | 30% ± 10% | |
| CD16-negative, CD56-bright natural killer cell, human | 9 studies | 25% ± 11% | |
| myeloid cell | 8 studies | 40% ± 16% | |
| natural killer cell | 7 studies | 23% ± 6% | |
| dendritic cell | 6 studies | 37% ± 15% | |
| hematopoietic stem cell | 5 studies | 34% ± 19% | |
| hematopoietic precursor cell | 4 studies | 45% ± 24% | |
| GABAergic neuron | 4 studies | 32% ± 11% | |
| glutamatergic neuron | 4 studies | 32% ± 12% | |
| monocyte | 4 studies | 30% ± 10% | |
| conventional dendritic cell | 3 studies | 24% ± 7% | |
| mononuclear phagocyte | 3 studies | 30% ± 10% | |
| hepatocyte | 3 studies | 25% ± 6% | |
| gamma-delta T cell | 3 studies | 24% ± 6% | |
| interneuron | 3 studies | 29% ± 14% |
